Nicole Gamache
Primary Care · Kenner, LANPI 1669733051
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations.
Across 13 payments — averaging $108.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$250
- AstraZeneca$233
- Gilead$200
- Abbott$128
- Teva Pharmaceuticals USA, Inc.$125
- Novo Nordisk$123
- plus $348 from 3 others
What the payments were for
- Food & beverage$1,407100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 2 | $250 |
| AstraZeneca(2 entities) | 3 | $233 |
| Gilead | 2 | $200 |
| Abbott | 1 | $128 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Novo Nordisk | 1 | $123 |
| Alkermes, Inc. | 1 | $120 |
| Dexcom, Inc. | 1 | $117 |
| Medtronic | 1 | $111 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre 2$128
- Humira$125
- AUSTEDO$125
- VRAYLAR$125
- Saxenda$123
- Wegovy$123
- VIVITROL$120
- DEXCOM G6 TRANSMITTER$117
- SYNCHROMEDII$111
- Strensiq$109
- Descovy$100
How this compares
$1,407 in reported general payments places this provider in the 65th percentile of 106 primary care providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AlvescoCiclesonide | 17 | $1,819 |
| Fluticasone Propionate | 49 | $883 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 43 | $590 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $539 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $450 |
| Atorvastatin Calcium | 28 | $374 |
| Cefadroxil | 34 | $351 |
| Doxycycline Monohydrate | 36 | $345 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 29 | $281 |
| Losartan Potassium | 17 | $254 |
| Amlodipine Besylate | 18 | $226 |
| Levothyroxine Sodium | 11 | $207 |
| Lisinopril | 15 | $169 |
| Prednisone | 23 | $152 |
| Triamcinolone Acetonide | 19 | $140 |
Paid to pharmacies, not to this prescriber.
Other primary care in Kenner
- Karen Chavez JonesKenner$4K
- Hanaiya Pritchett JonesKenner$2K
- Brittany MecheKenner$890
- Wendy TaylorShreveport$15K
- Jodi BurasCovington$14K
- Mia Schexnayder-DavisNew Orleans$10K
- Lourdes TorresMonroe$8K
- Danielle WebsterPrairieville$8K
- Alle NorrisCovington$6K
- Ariel GrahamRayville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.